SFRP5 is a Wnt5a antagonist, therefore, SFRP5 expression loss exaggerated the pro-inflammatory effects of Wnt5a, which was shown to be induced by obesity [44]. The gene discussed is WNT5A; the disease is obesity due to melanocortin 4 receptor deficiency.